ESR1 and breast carcinoma: In the current study, we suggest that 19 S proteasome inhibitors b-AP15 and PtPT can induce growth arrest and apoptosis in ER+ BCa cells, and have the tremendous potential for endocrine therapies-resistant ERα+ breast cancer or early stage ERα+ BCa.